Colombia Pharmaceuticals and Healthcare - Report Q4 2014

Business Monitor International
September 3, 2014
119 Pages - SKU: BMI5321302
Countries covered: Colombia

Colombia Pharmaceuticals and Healthcare - Report Q4 2014

BMI View: President Juan Manuel Santos' re-election in June has given him a strong mandate to continuethe process of healthcare reform in Colombia. Although the Santos administration has been successful inlimiting medicine price increases, financial problems will to plague the Colombian insurance system ifstructural issues are not addressed.

Headline Expenditure Projections

Pharmaceuticals: COP8,126bn (USD4.35bn) in 2013 to COP8,686bn (USD4.44bn) in 2014; +6.9% inlocal currency terms and +2.2% in US dollar terms. Forecasts revised down due to the strictimplementation of drug price controls and the promotion of generic drugs.

Healthcare: COP49,956bn (USD26.72bn) in 2013 to COP54,480bn (USD27.87bn) in 2014; +9.1% inlocal currency terms and +4.3% in US dollar terms. Forecasts revised up due to revised historicaldata.



More Prescription Drugs reports by Business Monitor International

Pharmaceuticals and Healthcare Report - Russia Q4 2104 by Business Monitor International
BMI View: Russia's cooling of relations with the West is putting pressure on foreign investment in thecountry. With the EU and the US applying further ...
Pharmaceuticals and Healthcare Report - Greece Q4 2104 by Business Monitor International
BMI View: The pharmaceutical and healthcare industry in Greece will continue to contract over theremainder of 2014. The government will seek to reduce public spending ...
Pharmaceuticals and Healthcare Report - Finland Q4 2104 by Business Monitor International
BMI View: An ageing population and the subsequent increased consumption of high-value prescriptionmedicines for the treatment of long-term illnesses will place a greater strain on ...
Pharmaceuticals and Healthcare Report - Oman Q4 2014 by Business Monitor International
BMI View: Despite its small size in comparison with other GCC countries, Oman will remain an attractivemarket to multinational pharmaceutical companies due to the high ...
See all reports like this >>

More Colombia Prescription Drugs reports

Pharmaceuticals and Healthcare Report - Colombia Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - Colombia Q4 2014BMI View: Revenue recorded by multinational pharmaceutical companies will continue to be constrainedin Colombia over the coming years ...
Pharmaceuticals and Healthcare : Colombia Pharmaceuticals and Healthcare Report Q3 2014 by Business Monitor International
Pharmaceuticals and Healthcare : Colombia Pharmaceuticals and Healthcare Report Q3 2014BMI View: Revenue recorded by multinational pharmaceutical companies will continue to be constrainedin Colombia over ...
Antibiotics Market in Colombia to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Colombia. The study provides essential market ...
The Pharmaceutical Market: Colombia by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!